Position in RPRX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$2,753,382
+$1,657,050 QoQ
Shares Held
57,398
+102.3% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
9 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALLSTATE CORP holds $61,025,515 across 41 Biotechnology names. RPRX ranks #4 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
21,523 | $9,610,880 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
10,953 | $8,462,725 | |
| 3 | INSM |
INSMED Inc
|
23,888 | $3,906,165 | |
| 4 | RPRX |
Royalty Pharma plc
This page
|
57,398 | $2,753,382 | |
| 5 | MRNA |
Moderna, Inc.
|
41,326 | $2,099,360 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,335 | $2,096,061 | |
| 7 | INCY |
Incyte Corp
|
22,098 | $2,079,863 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
64,608 | $1,789,641 |
All Filings in RPRX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,753,382 | 57,398 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $1,096,332 | 28,373 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $454,900 | 12,894 | Shares | Sole | 2025-10-29 | |
| 2025-03-31 | $554,767 | 17,821 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $298,926 | 11,718 | Shares | Sole | 2025-02-12 | |
| 2022-12-31 | $523,165 | 13,238 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $526,599 | 13,106 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $550,976 | 13,106 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $351,536 | 9,023 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||